-
Lawmakers removed some of the more controversial policies — like guidelines for the 340B Drug Pricing Program and site neutrality — in the process.
-
Several bills this session deal with a federal program known as the 340B Drug Pricing Program. Lawmakers say the measures tackle health care costs, but some health leaders say lawmakers may misunderstand what that program is and what it’s for.
-
The next president will face decisions on drug price negotiations, enhanced subsidies for Affordable Care Act plans and medication abortion among other issues. Here's where the candidates stand.